PARAMETRIC PORTFOLIO ASSOCIATES LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$455,000
+15.8%
2,098
-38.4%
0.00%
Q4 2020$393,000
+10.4%
3,408
-6.9%
0.00%
Q3 2020$356,000
-94.0%
3,662
-92.5%
0.00%
-100.0%
Q2 2020$5,972,000
+8.0%
48,664
-22.9%
0.01%0.0%
Q1 2020$5,530,000
+14.7%
63,152
+37.0%
0.01%
+25.0%
Q4 2019$4,820,000
+10.2%
46,095
+21.2%
0.00%0.0%
Q3 2019$4,375,000
+375.5%
38,036
+612.4%
0.00%
+300.0%
Q2 2019$920,000
+11.2%
5,339
+8.8%
0.00%0.0%
Q1 2019$827,000
+72.3%
4,907
-0.3%
0.00%
Q4 2018$480,000
-37.2%
4,924
+11.4%
0.00%
-100.0%
Q3 2018$764,000
+53.1%
4,422
+23.6%
0.00%
Q2 2018$499,000
+31.0%
3,579
+5.8%
0.00%
Q1 2018$381,000
-15.0%
3,384
-0.3%
0.00%
Q4 2017$448,000
+28.4%
3,393
-1.2%
0.00%
Q3 2017$349,000
+2.6%
3,434
+1.1%
0.00%
Q2 2017$340,000
-45.2%
3,395
-33.8%
0.00%
-100.0%
Q1 2017$621,000
+31.3%
5,132
+21.4%
0.00%0.0%
Q4 2016$473,000
-52.3%
4,229
-43.4%
0.00%0.0%
Q3 2016$991,000
-16.5%
7,470
-42.4%
0.00%
-50.0%
Q2 2016$1,187,000
+143.7%
12,963
+92.1%
0.00%
+100.0%
Q1 2016$487,000
+110.8%
6,747
+102.7%
0.00%
Q4 2015$231,000
-24.0%
3,3280.0%0.00%
-100.0%
Q3 2015$304,000
-25.7%
3,3280.0%0.00%0.0%
Q2 2015$409,000
+35.0%
3,3280.0%0.00%0.0%
Q1 2015$303,000
+34.7%
3,3280.0%0.00%
Q4 2014$225,0003,3280.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders